
1. antiviral res. 2014 dec;112:91-102. doi: 10.1016/j.antiviral.2014.10.007. epub
2014 oct 23.

a stably expressed llama single-domain intrabody targeting rev displays
broad-spectrum anti-hiv activity.

boons e(1), li g(2), vanstreels e(3), vercruysse t(4), pannecouque c(5), vandamme
am(6), daelemans d(7).

author information: 
(1)rega institute medical research, laboratory virology chemotherapy, 
department microbiology immunology, ku leuven, minderbroedersstraat 10,
leuven b-3000, belgium. electronic address: eline.boons@rega.kuleuven.be.
(2)rega institute medical research, laboratory clinical and
epidemiological virology, department microbiology immunology, ku leuven,
minderbroedersstraat 10, leuven b-3000, belgium. electronic address:
guangdi.li@rega.kuleuven.be.
(3)rega institute medical research, laboratory virology chemotherapy, 
department microbiology immunology, ku leuven, minderbroedersstraat 10,
leuven b-3000, belgium. electronic address: els.vanstreels@rega.kuleuven.be.
(4)rega institute medical research, laboratory virology chemotherapy, 
department microbiology immunology, ku leuven, minderbroedersstraat 10,
leuven b-3000, belgium. electronic address: thomas.vercruysse@rega.kuleuven.be.
(5)rega institute medical research, laboratory virology chemotherapy, 
department microbiology immunology, ku leuven, minderbroedersstraat 10,
leuven b-3000, belgium. electronic address:
christophe.pannecouque@rega.kuleuven.be.
(6)rega institute medical research, laboratory clinical and
epidemiological virology, department microbiology immunology, ku leuven,
minderbroedersstraat 10, leuven b-3000, belgium; centro de malária e outras
doenças tropicais unidade de microbiologia, instituto de higiene e medicina
tropical, universidade nova de lisboa, lisboa 1349-008, portugal. electronic
address: annemie.vandamme@uzleuven.be.
(7)rega institute medical research, laboratory virology chemotherapy, 
department microbiology immunology, ku leuven, minderbroedersstraat 10,
leuven b-3000, belgium. electronic address: dirk.daelemans@rega.kuleuven.be.

the hiv rev protein mediates transport partially unspliced hiv mrna
from nucleus cytoplasm. rev multimerizes secondary stem-loop
structure present viral intron-containing mrna species recruits the
cellular karyopherin crm1 export viral mrnas nucleus the
cytoplasm. previously identified single-domain intrabody (nb(190)),
derived llama heavy-chain antibody, efficiently inhibits rev
multimerization suppresses production infectious virus. recently
mapped epitope nanobody demonstrated rev residues k20 and
y23 crucial interaction residues v16, h53 l60 important 
a lesser extent. here, generated cell lines stably expressing nb(190) and
assessed capacity cell lines suppress replication of
different hiv-1 subtypes. cells stably expressing single-domain
antibody protected virus-induced cytopathogenic effect even the
context high multiplicity infection. addition, replication of
different subtypes group one strain group significantly
suppressed cell lines. next, analysed natural variations rev
amino acids sequence samples hiv-1 infected patients worldwide and
assessed effect nb(190) prevalent polymorphisms occurring at
the key epitope positions (k20 y23) rev. found nb(190) able to
suppress function rev variants except k20n mutant, was
present 0.7% hiv-1 sequence populations (n = 4632). cells stably
expressing single-domain intrabody nb(190) protected against
virus-induced cytopathogenic effect display selective survival advantage
upon infection. addition, nb(190) suppresses replication wide range
of different hiv-1 subtypes. large-scale sequence analysis reveals the
nb(190) epitope positions rev well conserved across major hiv-1 subtypes
and groups. altogether, results indicate nb(190) may broad
potential gene therapeutic agent hiv-1.

copyright © 2014 elsevier b.v. rights reserved.

doi: 10.1016/j.antiviral.2014.10.007 
pmid: 25453342  [indexed medline]

